5-Aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream

Digestive Diseases and Sciences

Volumn 56, Issue 4, 2011, Pages 1037-1046

  Caltabiano, Caroline ^a,c   Máximo, Felipe Rodrigues ^b,d   Spadari, Ana Paula Pimentel ^b,d   Da Conceição Miranda, Daniel Duarte ^a,e   Serra, Marcia Milena Pivatto ^a,e   Ribeiro, Marcelo Lima ^a,e   Martinez, Carlos Augusto Real ^a,f  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

^b UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^c São Francisco University Medical School ^*  (Brazil)

^d 255 ^*  (Brazil)

^e NONE   (Brazil)

^f Rua Rui Barbosa 255   (Brazil)

Author keywords

5 Aminosalicylic acid; Butyrates; Colitis; Fatty acids; Mesalamine; Rats; Volatile

Indexed keywords

ENEMA; HYDROGEN PEROXIDE; MESALAZINE; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON LAVAGE; COLON MUCOSA; COLOSTOMY; COMET ASSAY; CONTROLLED STUDY; DIVERSION COLITIS; DNA DAMAGE; DRUG EFFICACY; HISTOLOGY; INTESTINE EPITHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 79955623965     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1378-z     Document Type: Article

References (67)

1. Glotzer DJ, Glick ME, Goldman H. Proctitis and colitis following diversion of fecal stream. Gastroenterology. 1981;80:438-441. (Pubitemid 11183942)
2. Bosshardt RT, Abel ME. Proctitis following fecal diversion. Dis Colon Rectum. 1984;27:605-607. (Pubitemid 14028634)
3. Geraghty JM, Talbot IC. Diversion colitis: histological features in the colon and rectum after defunctioning colostomy. Gut. 1991;32:1020-1023.
4. Lavoine E, Vissuzaine C, Cadiot G, et al. Proctitis of diversion on an excluded rectum in patients with hemorrhagic rectocolitis. Gastroenterol Clin Biol. 1996;20:243-247.
5. Haas PA, Haas GP. A critical evaluation of the Hartmann's procedure. Am Sur. 1988;54:380-385.
6. Keli E, Bouchoucha M, Devroede G, et al. Diversion-related experimental colitis in rats. Dis Colon Rectum. 1997;40:222-228. (Pubitemid 27074296)
7. Frisbie JH, Ahmed N, Hirano I, et al. Diversion colitis in patients with myelopathy: clinical, endoscopic, and histopathological findings. J Spinal Cord Med. 2000;23:142-149.
8. Bax TW, McNevin MS. The value of diverting loop ileostomy on the high-risk colon and rectal anastomosis. Am J Surg. 2007;193:585-587.
9. Koutroubakis IE. Spectrum of non-inflammatory bowel disease and non-infectious colitis. World J Gastroenterol. 2008;14:7277-7279.
10. Habr-Gama A, Teixeira MG, Vieira MJF, et al. Operaçäo de Hartmann e suas conseqüências. Rev Bras Coloproctol. 1997;17:5-10.
11. David GG, Al-Sarira AA, Willmott S, et al. Use of Hartmann's procedure in England. Colorectal Dis. 2009;11:308-312.
12. Curi A, Mascarenhas JCS, Moreira Junior H, et al. Morbimortalidade associada à reconstrução do trânsito intestinal - Análise de 67 casos. Rev Bras Coloproct. 2002;22:88-97.
13. Neut C, Guillemot F, Colombel JF. Nitrate-reducing bacteria in diversion colitis: a clue to inflammation? Dig Dis Sci. 1997;42:2577-2580.
14. Villanacci V, Talbot IC, Rossi E, et al. Ischaemia: a pathogenetic clue in diversion colitis? Colorectal Dis. 2007;9:601-605.
15. Roediger WE, Rae DA. Trophic effect of short chain fatty acids on mucosal handling of ions by the defunctioned colon. Br J Surg. 1982;69:23-25. (Pubitemid 12253604)
16. Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23-28. (Pubitemid 19033059)
17. Neut C, Guillemot F, Gower-Rousseau C, et al. Treatment of diversion colitis with shorty-chain fatty acids. Bacteriological study. Gastroenterol Clin Biol. 1995;19:871-875.
18. Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci. 1996;41:2477-2481.
19. Oliveira-Neto JP, Aguilar-Nascimento JE. Intraluminal irrigations with fibers improves mucosal inflammation and atrophy in diversion colitis. Nutrition. 2004;20:197-199. (Pubitemid 38220982)
20. Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7:563-567.
21. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243. (Pubitemid 44309560)
22. Fillmann H, Kretzmann NA, San-Miguel B, et al. Glutamine inhibits over-expression of pro-inflammatory genes and downregulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217-226. (Pubitemid 46977112)
23. Nassri CGG, Nassri AB, Favero E, et al. Influência da irrigação de soluções nutricionais no colo excluso de trânsito intestinal. Estudo experimental em ratos. Rev Bras Coloproct. 2008;28: 306-314.
24. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:79-94. (Pubitemid 34052583)
25. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol. 2005;11:2371-2384. (Pubitemid 40667968)
26. Nieto N, Torres MI, Ríos A, et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr. 2002;132:11-19. (Pubitemid 34042448)
27. Roediger WE, Truelove SC. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979;20:484-488. (Pubitemid 9208999)
28. Roediger WE. The starved colon - diminished mucosal nutrition, diminished absorption, and colitis. Dis Colon Rectum. 1990;33:858-862. (Pubitemid 20350504)
29. Liu Q, Shimoyama T, Suzuki K, et al. Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. Scand J Gastroenterol. 2001;36:744-750. (Pubitemid 32568553)
30. Rosignoli P, Fabiani R, De Bartolomeu A, et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis. 2001;22:1675-1680.
31. Halliwell B, Gutteridge JM. Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem. 1997;69:1330-1331. (Pubitemid 27364860)
32. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med. 2000;29:222-230.
33. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci. 2000;899:136-147.
34. Møller P. The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures. Basic Clin Pharmacol Toxicol. 2006;98:336-345.
35. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132-148. (Pubitemid 26129312)
36. McCord JM. The evolution of free radicals and oxidative stress. Am J Med. 2000;108:652-659. (Pubitemid 30336605)
37. Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Englebreth-Holm-Swarm matrix. Am J Pathol. 1997;151:215-231. (Pubitemid 27283973)
38. Martinez CA, Bartocci PC, do Carmo CV, Pereira JA, Miranda DD, Ribeiro ML. The effects of oxidative DNA damage and mutations in the p53 protein on cells of the colonic mucosa with and without the fecal stream: an experimental study in rats. Scand J Gastroenterol. 2010;45:714-724.
39. Longatti TS, Acedo SC, de Oliveira CC, et al. Inflammatory alterations in excluded colon in rats - a comparison with chemically-induced colitis. Scand J Gastroenterol. 2010;45:315-324.
40. Triantafillidis JK, Nicolakis D, Mountaneas G, et al. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas. Am J Gastroenterol. 1991;86:1552-1553.
41. Tripodi J, Gorcey S, Burakoff R. A case of diversion colitis treated with 5-aminosalicylic acid enemas. Am J Gastroenterol. 1992;87:645-647.
42. Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgraduat Med J. 2006;82:130-135. (Pubitemid 43266142)
43. Ancha HR, Kurella RR, McKimmey CC, et al. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats. Exp Biol Med (Maywood). 2008;233:1301-1308.
44. Ancha HR, Kurella RR, McKimmey CC, et al. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci. 2009;54:758-766.
45. Cortot A, Maetz D, Degoutte E, et al. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Am J Gastroenterol. 2008;103:3106-3114.
46. Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184-191.
47. Agarwal VP, Schimmel EM. Diversion colitis: a nutritional deficiency syndrome? Nutr Rev. 1989;47:257-261.
48. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut. 1990;31:786-790. (Pubitemid 20233945)
49. Sousa MV, Priolli DG, Portes AV, et al. Evaluation by computerized morphometry of histopathological alterations of the colon wall in segments with and without intestinal transit in rats. Acta Cir Bras. 2008;23:417-424.
50. Nonose R, Spadari APP, Priolli DG, et al. Tissue quantification of neutral and acid mucins in the mucosa of the colon with and without fecal stream: experimental study in rats. Acta Cir Bras. 2009;24:267-275.
51. Miyashi Y, Yoshioka A, Iamamura S, et al. Effect of sulphasalazine and its metebolites on the generation of reactive oxygen species. Gut. 1987;28:190-195. (Pubitemid 17027390)
52. Conner E, Brand S, Davis J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis. 1996;2:133-147. (Pubitemid 126727679)
53. Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41:18-26. (Pubitemid 47266169)
54. Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive metabolities in inflammatory bowel disease. Gastroenterology. 1992;103:186-196.
55. Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996;39:407-415. (Pubitemid 26338530)
56. Guijarro LG, Mate J, Gisbert JP, et al. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol. 2008;14:2851-2857.
57. Nikfar S, Rahimi R, Rezaie A, et al. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci. 2009;54:1157-1170.
58. Ikeda I, Ominoto A, Wada K, et al. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. Clin Cancer Res. 2007;13:6527-6531. (Pubitemid 350075044)
59. Ribeiro ML, Priolli DG, Miranda DDC, et al. Analysis of oxidative DNA damage in patients with colorectal cancer. Clin Colorectal Cancer. 2008;7:267-272.
60. Siddiqui A, Ancha H, Tedesco D, et al. Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis. Dig Dis Sci. 2006;51:698-705.
61. Aslan A, Temiz M, Atik E, et al. Effectiveness of mesalamine and propolis in experimental colitis. Adv Ther. 2007;24:1085-1097. (Pubitemid 350274788)
62. dos Reis SB, de Oliveira CC, Acedo SC, et al. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother Res. 2009;23:324-329.
63. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24:353-362. (Pubitemid 36432628)
64. Wentzel JF, Gouws C, Huysamen C, DyK EV, Koekemoer G, Pretorius PJ. Assessing the DNA methylation status of single cells with comet assay. Anal Biochem. 2010 Feb 13 [Epub ahead of print].
65. Naganuma M, Iwao Y, Ogata H, et al. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. Inflamm Bowel Dis. 2001;7:221-225. (Pubitemid 32776515)
66. Lakatos PL, Lakatos L. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opin Pharmacother. 2008;9:741-749. (Pubitemid 351566191)
67. Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol. 2000;95:1628-1636. (Pubitemid 30484995)